scholarly journals RAPID URINE SCREENING FOR BACTERIURIA IN CHILDREN USING MICROBIOLOGY ANALYZER, COMBINING PHOTOMETRIC AND COHERENT FLUCTUATION NEPHELOMETRIC METHODS

2017 ◽  
Vol 6 (4) ◽  
pp. 395-398 ◽  
Author(s):  
A. S. Gur’ev ◽  
O. Yu. Kuznetsova ◽  
M. F. Pyasetskaya ◽  
I. A. Smirnova ◽  
N. A. Belyaeva ◽  
...  
2015 ◽  
Vol 159 (1) ◽  
pp. 107-110 ◽  
Author(s):  
A. S. Gur’ev ◽  
A. Yu. Volkov ◽  
I. I. Dolgushin ◽  
A. V. Pospelova ◽  
S. F. Rastopov ◽  
...  

2015 ◽  
Vol 159 (3) ◽  
pp. 412-412 ◽  
Author(s):  
A. S. Gur’ev ◽  
A. Yu. Volkov ◽  
I. I. Dolgushin ◽  
A. V. Pospelova ◽  
S. F. Rastopov ◽  
...  

1993 ◽  
Vol 2 (3) ◽  
pp. 207-211 ◽  
Author(s):  
Andrew J. Saxon ◽  
Donald A. Calsyn ◽  
Diane Greenberg ◽  
Paul Blaes ◽  
Virginia M. Haver ◽  
...  
Keyword(s):  

2021 ◽  
Vol 7 (1) ◽  
pp. 18
Author(s):  
Christiane Auray-Blais ◽  
Michel Boutin ◽  
Pamela Lavoie ◽  
Bruno Maranda

The Quebec Neonatal Urine Screening Program was initiated in 1971 with overall screening inception of newborns in 1973. Forty-seven years later, over 3.5 million babies have been screened for up to 25 inborn errors of metabolism divided into two groups: (1) urea cycle disorders and organic acidurias; and (2) disorders of amino acid metabolism and transport. The main goal of this preventive genetic medicine program is the detection of treatable diseases before the onset of clinical symptoms. Urine specimens from 21-day-old babies are collected and dried on filter paper by parents at home. The participation is voluntary with a high compliance rate over the years (~90%). Specimens are analyzed by thin layer chromatography (TLC). The main objective of this evaluative research project was to assess the feasibility of a technological upgrade towards mass spectrometry. A 2.85-min flow injection method was devised, normal values established, and abnormal profiles confirmed using second-tier tests. The validated assays are sensitive, specific, and suitable for populational screening, as well as for high-risk screening laboratories. Triple H syndrome, which would not be detected in newborns by blood screening at two days of age was found to be positive in the urine of an affected patient.


1993 ◽  
Vol 39 (4) ◽  
pp. 698-699 ◽  
Author(s):  
D Simpson ◽  
D R Jarvie ◽  
F M Moore

Author(s):  
Toshihiro Shinka ◽  
Yoshito Inoue ◽  
Hai Peng ◽  
Xia Zhen-Wei ◽  
Morimasa Ose ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Çiğdem Karakükcü ◽  
Mehmet Zahid Çıracı ◽  
Derya Kocer ◽  
Mine Yüce Faydalı ◽  
Muhittin Abdulkadir Serdar

Abstract Objectives To obtain optimal immunoassay screening and LC-MS/MS confirmation cut-offs for opiate group tests to reduce false positive (FP) and false negative (FN) rates. Methods A total of 126 urine samples, −50 opiate screening negative, 76 positive according to the threshold of 300 ng/mL by CEDIA method – were confirmed by a full-validated in-house LC-MS/MS method. Sensitivity, specificity, FP, and FN rates were determined at cut-off concentrations of both 300 and 2,000 ng/mL for morphine and codeine, and 10 ng/mL for heroin metabolite 6-mono-acetyl-morphine (6-MAM). Results All CEDIA opiate negative urine samples were negative for morphine, codeine and 6-MAM. Although sensitivity was 100% for each cut-off; specificity was 54.9% at CEDIA cut-off 300 ng/mL vs. LC-MS/MS cut-off 300 ng/mL and, 75% at CEDIA cut-off 2,000 ng/mL vs. LC-MS/MS cut-off 2,000 ng/mL. False positive rate was highest (45.1%) at CEDIA cut-off 300 ng/mL. At CEDIA cut-off 2,000 ng/mL vs. LC-MS/MS cut-off 300 ng/mL, specificity increased to 82.4% and FP rate decreased to 17.6%. All 6-MAM positive samples had CEDIA concentration ≥2,000 ng/mL. Conclusions 2,000 ng/mL for screening and 300 ng/mL for confirmation cut-offs are the most efficient thresholds for the lowest rate of FP opiate results.


Sign in / Sign up

Export Citation Format

Share Document